Thrombophilia Screening After Severe IUGR


This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Full Title of Study: “Thrombophilia Screening in Women After Severe IUGR”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: October 2022


  • Biological: thrombophilia screening
    • In the IUGR group systematic thrombophilia screening had already been performed.

Arms, Groups and Cohorts

  • pregnant women with severe IUGR

Clinical Trial Outcome Measures

Primary Measures

  • Rate of positive’s thrombophilia screening
    • Time Frame: 5 years

Participating in This Clinical Trial

Inclusion Criteria

  • Women over 18 years old – Pregnant women – IUGR defined by an EFW <3rd centile – IUGR before 25 GW Exclusion Criteria:

  • none

Gender Eligibility: Female

Pregnant women

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Central Hospital, Nancy, France
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.